Viral whole genome sequencing reveals high variations in APOBEC3 editing between HPV risk categories

High‐risk human papillomavirus (HPV) infections are responsible for cervical cancer. However, little is known about the differences between HPV types and risk categories regarding their genetic diversity and particularly APOBEC3‐induced mutations – which contribute to the innate immune response to H...

Full description

Saved in:
Bibliographic Details
Published inJournal of medical virology Vol. 96; no. 10; pp. e70002 - n/a
Main Authors Ferré, Valentine Marie, Coppée, Romain, Gbeasor‐Komlanvi, Fifonsi A., Vacher, Sophie, Bridier‐Nahmias, Antoine, Bucau, Margot, Salou, Mounerou, Lameiras, Sonia, Couvelard, Anne, Dagnra, Anoumou Claver, Bieche, Ivan, Descamps, Diane, Ekouevi, Didier K., Ghosn, Jade, Charpentier, Charlotte
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.10.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract High‐risk human papillomavirus (HPV) infections are responsible for cervical cancer. However, little is known about the differences between HPV types and risk categories regarding their genetic diversity and particularly APOBEC3‐induced mutations – which contribute to the innate immune response to HPV. Using a capture‐based next‐generation sequencing, 156 HPV whole genome sequences covering 43 HPV types were generated from paired cervical and anal swabs of 30 Togolese female sex workers (FSWs) sampled in 2017. Genetic diversity and APOBEC3‐induced mutations were assessed at the viral whole genome and gene levels. Thirty‐four pairwise sequence comparisons covering 24 HPV types in cervical and anal swabs revealed identical infections in the two anatomical sites. Differences in genetic diversity among HPV types was observed between patients. The E6 gene was significantly less conserved in low‐risk HPVs (lrHPVs) compared to high‐risk HPVs (hrHPVs) (p = 0.009). APOBEC3‐induced mutations were found to be more common in lrHPVs than in hrHPVs (p = 0.005), supported by our data and by using large HPV sequence collections from the GenBank database. Focusing on the most common lrHPVs 6 and 11 and hrHPVs 16 and 18, APOBEC3‐induced mutations were predominantly found in the E4 and E6 genes in lrHPVs, but were almost absent in these genes in hrHPVs. The variable APOBEC3 mutational signatures could contribute to the different oncogenic potentials between HPVs. Further studies are needed to conclusively determine whether APOBEC3 editing levels are associated to the carcinogenic potential of HPVs at the type and sublineage scales.
AbstractList High-risk human papillomavirus (HPV) infections are responsible for cervical cancer. However, little is known about the differences between HPV types and risk categories regarding their genetic diversity and particularly APOBEC3-induced mutations - which contribute to the innate immune response to HPV. Using a capture-based next-generation sequencing, 156 HPV whole genome sequences covering 43 HPV types were generated from paired cervical and anal swabs of 30 Togolese female sex workers (FSWs) sampled in 2017. Genetic diversity and APOBEC3-induced mutations were assessed at the viral whole genome and gene levels. Thirty-four pairwise sequence comparisons covering 24 HPV types in cervical and anal swabs revealed identical infections in the two anatomical sites. Differences in genetic diversity among HPV types was observed between patients. The E6 gene was significantly less conserved in low-risk HPVs (lrHPVs) compared to high-risk HPVs (hrHPVs) (p = 0.009). APOBEC3-induced mutations were found to be more common in lrHPVs than in hrHPVs (p = 0.005), supported by our data and by using large HPV sequence collections from the GenBank database. Focusing on the most common lrHPVs 6 and 11 and hrHPVs 16 and 18, APOBEC3-induced mutations were predominantly found in the E4 and E6 genes in lrHPVs, but were almost absent in these genes in hrHPVs. The variable APOBEC3 mutational signatures could contribute to the different oncogenic potentials between HPVs. Further studies are needed to conclusively determine whether APOBEC3 editing levels are associated to the carcinogenic potential of HPVs at the type and sublineage scales.
Abstract High‐risk human papillomavirus (HPV) infections are responsible for cervical cancer. However, little is known about the differences between HPV types and risk categories regarding their genetic diversity and particularly APOBEC3‐induced mutations – which contribute to the innate immune response to HPV. Using a capture‐based next‐generation sequencing, 156 HPV whole genome sequences covering 43 HPV types were generated from paired cervical and anal swabs of 30 Togolese female sex workers (FSWs) sampled in 2017. Genetic diversity and APOBEC3‐induced mutations were assessed at the viral whole genome and gene levels. Thirty‐four pairwise sequence comparisons covering 24 HPV types in cervical and anal swabs revealed identical infections in the two anatomical sites. Differences in genetic diversity among HPV types was observed between patients. The E6 gene was significantly less conserved in low‐risk HPVs (lrHPVs) compared to high‐risk HPVs (hrHPVs) ( p = 0.009). APOBEC3‐induced mutations were found to be more common in lrHPVs than in hrHPVs ( p = 0.005), supported by our data and by using large HPV sequence collections from the GenBank database. Focusing on the most common lrHPVs 6 and 11 and hrHPVs 16 and 18, APOBEC3‐induced mutations were predominantly found in the E4 and E6 genes in lrHPVs, but were almost absent in these genes in hrHPVs. The variable APOBEC3 mutational signatures could contribute to the different oncogenic potentials between HPVs. Further studies are needed to conclusively determine whether APOBEC3 editing levels are associated to the carcinogenic potential of HPVs at the type and sublineage scales.
High-risk human papillomavirus (HPV) infections are responsible for cervical cancer. However, little is known about the differences between HPV types and risk categories regarding their genetic diversity and particularly APOBEC3-induced mutations - which contribute to the innate immune response to HPV. Using a capture-based next-generation sequencing, 156 HPV whole genome sequences covering 43 HPV types were generated from paired cervical and anal swabs of 30 Togolese female sex workers (FSWs) sampled in 2017. Genetic diversity and APOBEC3-induced mutations were assessed at the viral whole genome and gene levels. Thirty-four pairwise sequence comparisons covering 24 HPV types in cervical and anal swabs revealed identical infections in the two anatomical sites. Differences in genetic diversity among HPV types was observed between patients. The E6 gene was significantly less conserved in low-risk HPVs (lrHPVs) compared to high-risk HPVs (hrHPVs) (p = 0.009). APOBEC3-induced mutations were found to be more common in lrHPVs than in hrHPVs (p = 0.005), supported by our data and by using large HPV sequence collections from the GenBank database. Focusing on the most common lrHPVs 6 and 11 and hrHPVs 16 and 18, APOBEC3-induced mutations were predominantly found in the E4 and E6 genes in lrHPVs, but were almost absent in these genes in hrHPVs. The variable APOBEC3 mutational signatures could contribute to the different oncogenic potentials between HPVs. Further studies are needed to conclusively determine whether APOBEC3 editing levels are associated to the carcinogenic potential of HPVs at the type and sublineage scales.High-risk human papillomavirus (HPV) infections are responsible for cervical cancer. However, little is known about the differences between HPV types and risk categories regarding their genetic diversity and particularly APOBEC3-induced mutations - which contribute to the innate immune response to HPV. Using a capture-based next-generation sequencing, 156 HPV whole genome sequences covering 43 HPV types were generated from paired cervical and anal swabs of 30 Togolese female sex workers (FSWs) sampled in 2017. Genetic diversity and APOBEC3-induced mutations were assessed at the viral whole genome and gene levels. Thirty-four pairwise sequence comparisons covering 24 HPV types in cervical and anal swabs revealed identical infections in the two anatomical sites. Differences in genetic diversity among HPV types was observed between patients. The E6 gene was significantly less conserved in low-risk HPVs (lrHPVs) compared to high-risk HPVs (hrHPVs) (p = 0.009). APOBEC3-induced mutations were found to be more common in lrHPVs than in hrHPVs (p = 0.005), supported by our data and by using large HPV sequence collections from the GenBank database. Focusing on the most common lrHPVs 6 and 11 and hrHPVs 16 and 18, APOBEC3-induced mutations were predominantly found in the E4 and E6 genes in lrHPVs, but were almost absent in these genes in hrHPVs. The variable APOBEC3 mutational signatures could contribute to the different oncogenic potentials between HPVs. Further studies are needed to conclusively determine whether APOBEC3 editing levels are associated to the carcinogenic potential of HPVs at the type and sublineage scales.
Author Vacher, Sophie
Coppée, Romain
Bieche, Ivan
Charpentier, Charlotte
Salou, Mounerou
Descamps, Diane
Ghosn, Jade
Ekouevi, Didier K.
Bridier‐Nahmias, Antoine
Gbeasor‐Komlanvi, Fifonsi A.
Dagnra, Anoumou Claver
Bucau, Margot
Ferré, Valentine Marie
Lameiras, Sonia
Couvelard, Anne
Author_xml – sequence: 1
  givenname: Valentine Marie
  orcidid: 0000-0002-2196-6141
  surname: Ferré
  fullname: Ferré, Valentine Marie
  email: valentinemarie.ferre@aphp.fr
  organization: Service de Virologie, AP‐HP, Hôpital Bichat – Claude Bernard
– sequence: 2
  givenname: Romain
  orcidid: 0000-0002-3024-5928
  surname: Coppée
  fullname: Coppée, Romain
  email: romain.coppee@inserm.fr
  organization: Université Paris Cité, Inserm IAME UMR 1137
– sequence: 3
  givenname: Fifonsi A.
  surname: Gbeasor‐Komlanvi
  fullname: Gbeasor‐Komlanvi, Fifonsi A.
  organization: Centre Africain de Recherche en Epidémiologie et en Santé Publique (CARESP)
– sequence: 4
  givenname: Sophie
  surname: Vacher
  fullname: Vacher, Sophie
  organization: Institut Curie, PSL Research University
– sequence: 5
  givenname: Antoine
  surname: Bridier‐Nahmias
  fullname: Bridier‐Nahmias, Antoine
  organization: Université Paris Cité, Inserm IAME UMR 1137
– sequence: 6
  givenname: Margot
  surname: Bucau
  fullname: Bucau, Margot
  organization: AP‐HP, Hôpital Bichat‐Claude Bernard
– sequence: 7
  givenname: Mounerou
  surname: Salou
  fullname: Salou, Mounerou
  organization: Université de Lomé, Centre de Biologie Moléculaire et d'Immunologie
– sequence: 8
  givenname: Sonia
  surname: Lameiras
  fullname: Lameiras, Sonia
  organization: Institut Curie, Genomics of Excellence (ICGex) Platform, PSL Research University
– sequence: 9
  givenname: Anne
  surname: Couvelard
  fullname: Couvelard, Anne
  organization: Université de Paris, Centre of Research on Inflammation
– sequence: 10
  givenname: Anoumou Claver
  surname: Dagnra
  fullname: Dagnra, Anoumou Claver
  organization: Programme national de lutte contre le sida et les infections sexuellement transmissibles
– sequence: 11
  givenname: Ivan
  surname: Bieche
  fullname: Bieche, Ivan
  organization: INSERM U1016, Faculty of Pharmaceutical and Biological Sciences, Paris Cité University
– sequence: 12
  givenname: Diane
  surname: Descamps
  fullname: Descamps, Diane
  organization: Service de Virologie, AP‐HP, Hôpital Bichat – Claude Bernard
– sequence: 13
  givenname: Didier K.
  surname: Ekouevi
  fullname: Ekouevi, Didier K.
  organization: ISPED, Université de Bordeaux & Centre INSERM U1219 ‐ Bordeaux Population Health
– sequence: 14
  givenname: Jade
  orcidid: 0000-0003-2914-959X
  surname: Ghosn
  fullname: Ghosn, Jade
  organization: Service de Maladies Infectieuses et Tropicales, AP‐HP, Hôpital Bichat‐Claude Bernard
– sequence: 15
  givenname: Charlotte
  surname: Charpentier
  fullname: Charpentier, Charlotte
  organization: Service de Virologie, AP‐HP, Hôpital Bichat – Claude Bernard
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39400339$$D View this record in MEDLINE/PubMed
BookMark eNp10D1PAjEcx_HGaBTUwTdgmrjocNCHe-qoBEWjkUFZL73eHyjetdoeEN69RdTBxKkdPvmm_XXRvrEGEDqjpEcJYf1Fs-plJNz2UIcSkUaCZHQfdQiN0yhNaXKEut4vgsgFY4foiIuYEM5FB1UT7WSN13NbA56BsQ1gDx9LMEqbGXawAll7PNezOV5Jp2WrrfFYG3w9fr4ZDjiGSrdbWkK7BjB4NJ5gp_0bVrKFmXUa_Ak6mIYKnH6fx-j1dvgyGEWPz3f3g-vHSLEsZ1FGBadKVYKl06yitIQyiUHxckqgIomSKkkZEJZzzmVCykxRlScc4pxXiuWMH6PLXffd2fAF3xaN9grqWhqwS19wSlPOc5HEgV78oQu7dCa8bqtEThMWZ0Fd7ZRy1nsH0-Ld6Ua6TUFJsZ2-CNMXX9MHe_5dXJYNVL_yZ-sA-juw1jVs_i8VD0-TXfITmZ-OFw
Cites_doi 10.1038/s41467-020-14730-1
10.1038/nature12477
10.1016/j.virol.2014.12.028
10.1016/S1473-3099(19)30164-1
10.1097/OLQ.0b013e3181f70253
10.1038/ng.2702
10.1158/1055-9965.EPI-05-0460
10.1016/j.cmi.2019.04.015
10.1093/annonc/mdy003
10.1093/nar/gkw879
10.1016/j.virol.2015.08.017
10.1093/gigascience/giab008
10.1371/journal.ppat.1007755
10.1016/j.cyto.2021.155592
10.1093/infdis/jiy287
10.1128/JVI.02383-14
10.1128/JVI.00017-18
10.3390/v12121437
10.1128/JVI.01737-17
10.1007/s00404-013-2821-0
10.1086/516784
10.1016/S1470-2045(22)00270-4
10.1042/CS20050369
10.1530/JME-19-0011
10.1038/msb.2011.75
10.7150/ijms.34279
10.1128/mBio.02234-14
10.1016/S0022-2836(05)80360-2
10.1038/npjgenmed.2016.4
10.1093/bioinformatics/btp324
10.1002/ijc.27485
10.3390/v5112624
10.1186/s13027-020-00287-7
10.3390/v7052485
10.1093/jnci/djn044
10.1038/ng.2701
10.3390/v9080233
10.1371/journal.pone.0265269
10.1126/science.1153201
10.1016/j.jcv.2018.05.010
10.1038/314111a0
10.3390/microorganisms7070199
10.1002/ijc.31937
10.3390/pathogens10060773
10.1093/cid/cix135
10.1146/annurev-virology-092920-030354
10.1002/ijc.21655
10.1016/j.virol.2013.07.008
10.1016/j.cell.2017.08.001
10.1002/ijc.30716
10.1056/NEJMoa021641
ContentType Journal Article
Copyright 2024 The Author(s). published by Wiley Periodicals LLC.
2024 The Author(s). Journal of Medical Virology published by Wiley Periodicals LLC.
2024. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2024 The Author(s). published by Wiley Periodicals LLC.
– notice: 2024 The Author(s). Journal of Medical Virology published by Wiley Periodicals LLC.
– notice: 2024. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
WIN
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QL
7TK
7U9
8FD
C1K
FR3
H94
K9.
M7N
P64
RC3
7X8
DOI 10.1002/jmv.70002
DatabaseName Wiley-Blackwell Open Access Collection
Wiley Online Library Journals
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Bacteriology Abstracts (Microbiology B)
Neurosciences Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Genetics Abstracts
Virology and AIDS Abstracts
Technology Research Database
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList MEDLINE

CrossRef
Genetics Abstracts
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley-Blackwell Open Access Collection
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1096-9071
EndPage n/a
ExternalDocumentID 10_1002_jmv_70002
39400339
JMV70002
Genre researchArticle
Journal Article
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
24P
31~
33P
3O-
3SF
3WU
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFNX
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AHMBA
AI.
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
ECGQY
EJD
ELTNK
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
L7B
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M65
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RGB
RIWAO
RJQFR
ROL
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
V2E
VH1
W8V
W99
WBKPD
WHG
WIB
WIH
WIJ
WIK
WIN
WJL
WNSPC
WOHZO
WQJ
WRC
WUP
WXI
WXSBR
WYISQ
X7M
XG1
XPP
XV2
ZGI
ZXP
ZZTAW
~IA
~KM
~WT
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QL
7TK
7U9
8FD
C1K
FR3
H94
K9.
M7N
P64
RC3
7X8
ID FETCH-LOGICAL-c2782-71931ccd926f7d11beb54ec3bf0ed05cac562e028333a50b7c1c853e483dc2823
IEDL.DBID DR2
ISSN 0146-6615
1096-9071
IngestDate Thu Oct 17 17:16:48 EDT 2024
Thu Oct 24 04:33:02 EDT 2024
Wed Oct 30 12:30:23 EDT 2024
Sat Nov 02 12:03:54 EDT 2024
Thu Oct 24 09:52:39 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords whole genome sequencing
genetic diversity
cervical
APOBEC3
anal
human papillomavirus
Language English
License Attribution-NonCommercial-NoDerivs
2024 The Author(s). Journal of Medical Virology published by Wiley Periodicals LLC.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c2782-71931ccd926f7d11beb54ec3bf0ed05cac562e028333a50b7c1c853e483dc2823
Notes Valentine Marie Ferré and Romain Coppée contributed equally to the article as co‐first authors
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-2914-959X
0000-0002-3024-5928
0000-0002-2196-6141
OpenAccessLink https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjmv.70002
PMID 39400339
PQID 3119815247
PQPubID 105515
PageCount 10
ParticipantIDs proquest_miscellaneous_3116338954
proquest_journals_3119815247
crossref_primary_10_1002_jmv_70002
pubmed_primary_39400339
wiley_primary_10_1002_jmv_70002_JMV70002
PublicationCentury 2000
PublicationDate October 2024
2024-Oct
2024-10-00
20241001
PublicationDateYYYYMMDD 2024-10-01
PublicationDate_xml – month: 10
  year: 2024
  text: October 2024
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: London
PublicationTitle Journal of medical virology
PublicationTitleAlternate J Med Virol
PublicationYear 2024
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2013; 445
2019; 15
2017; 45
2022; 23
2013; 288
2019; 16
2019; 19
2020; 15
2020; 12
2020; 11
2008; 100
2013; 5
2017; 9
2015; 89
2012; 131
2014; 5
1990; 215
2019; 62
2018; 218
2019; 25
2019; 7
2017; 64
2018; 29
2009; 25
2018; 105
2021; 148
2013; 45
2013; 500
2015; 485
2017; 170
2006; 110
2008; 320
2011; 38
2006; 118
2015; 8
2015; 7
2019; 144
2011; 7
2021; 10
2016; 1
2003; 348
2007; 195
2022
2015; 476
2022; 9
2018; 92
1985; 314
2017; 141
2022; 17
2005; 14
e_1_2_9_31_1
e_1_2_9_52_1
e_1_2_9_50_1
e_1_2_9_10_1
e_1_2_9_35_1
e_1_2_9_56_1
e_1_2_9_12_1
e_1_2_9_33_1
e_1_2_9_54_1
e_1_2_9_14_1
e_1_2_9_39_1
e_1_2_9_16_1
Chen S (e_1_2_9_21_1) 2015; 8
e_1_2_9_37_1
e_1_2_9_18_1
e_1_2_9_41_1
e_1_2_9_20_1
e_1_2_9_22_1
e_1_2_9_45_1
e_1_2_9_24_1
e_1_2_9_43_1
e_1_2_9_8_1
e_1_2_9_6_1
e_1_2_9_4_1
e_1_2_9_2_1
e_1_2_9_26_1
e_1_2_9_49_1
e_1_2_9_28_1
e_1_2_9_47_1
e_1_2_9_30_1
e_1_2_9_53_1
e_1_2_9_51_1
e_1_2_9_11_1
e_1_2_9_34_1
e_1_2_9_13_1
e_1_2_9_32_1
e_1_2_9_55_1
e_1_2_9_15_1
e_1_2_9_38_1
e_1_2_9_17_1
e_1_2_9_36_1
e_1_2_9_19_1
e_1_2_9_42_1
e_1_2_9_40_1
e_1_2_9_46_1
e_1_2_9_23_1
e_1_2_9_44_1
e_1_2_9_7_1
e_1_2_9_5_1
e_1_2_9_3_1
e_1_2_9_9_1
e_1_2_9_25_1
e_1_2_9_27_1
e_1_2_9_48_1
e_1_2_9_29_1
References_xml – volume: 10
  year: 2021
  article-title: Twelve years of SAMtools and BCFtools
  publication-title: Gigascience
– volume: 29
  start-page: 563
  year: 2018
  end-page: 572
  article-title: Perspective: APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution
  publication-title: Ann Oncol
– volume: 5
  year: 2014
  article-title: Human papillomavirus E6 triggers upregulation of the antiviral and cancer genomic DNA deaminase APOBEC3B
  publication-title: mBio
– volume: 45
  start-page: 970
  issue: 9
  year: 2013
  end-page: 976
  article-title: An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers
  publication-title: Nat Genet
– volume: 476
  start-page: 341
  year: 2015
  end-page: 344
  article-title: International standardization and classification of human papillomavirus types
  publication-title: Virology
– volume: 105
  start-page: 64
  year: 2018
  end-page: 71
  article-title: Prevalence of cervical, oral, and anal human papillomavirus infection in women living with HIV in Denmark ‐ the SHADE cohort study
  publication-title: J Clin Virol
– volume: 100
  start-page: 513
  year: 2008
  end-page: 517
  article-title: Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections
  publication-title: J Natl Cancer Inst
– volume: 38
  start-page: 253
  year: 2011
  end-page: 259
  article-title: Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV‐infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study)
  publication-title: Sex Transm Dis
– volume: 17
  year: 2022
  article-title: Oral, genital and anal human papillomavirus infections among female sex workers in Ibadan, Nigeria
  publication-title: PLoS One
– volume: 288
  start-page: 667
  year: 2013
  end-page: 672
  article-title: Coexisting anal human papilloma virus infection in heterosexual women with cervical HPV infection
  publication-title: Arch Gynecol Obstet
– volume: 64
  start-page: 1228
  year: 2017
  end-page: 1235
  article-title: Carcinogenicity of human papillomavirus (HPV) types in HIV‐Positive women: a meta‐analysis from HPV infection to cervical cancer
  publication-title: Clin Infect Dis
– volume: 89
  start-page: 688
  year: 2015
  end-page: 702
  article-title: APOBEC3A functions as a restriction factor of human papillomavirus
  publication-title: J Virol
– volume: 7
  start-page: 539
  year: 2011
  article-title: Fast, scalable generation of high‐quality protein multiple sequence alignments using Clustal Omega
  publication-title: Mol Syst Biol
– volume: 16
  start-page: 1042
  year: 2019
  end-page: 1049
  article-title: Human papillomavirus type 16 E1 mutations associated with cervical cancer in a han Chinese population
  publication-title: Int J Med Sci
– volume: 19
  start-page: 880
  year: 2019
  end-page: 891
  article-title: Cervical determinants of anal HPV infection and high‐grade anal lesions in women: a collaborative pooled analysis
  publication-title: Lancet Infect Dis
– volume: 141
  start-page: 664
  year: 2017
  end-page: 670
  article-title: Worldwide burden of cancer attributable to HPV by site, country and HPV type
  publication-title: Int J Cancer
– volume: 320
  start-page: 230
  year: 2008
  end-page: 233
  article-title: Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions
  publication-title: Science
– volume: 7
  start-page: 199
  year: 2019
  article-title: The Host‐Microbe interplay in human Papillomavirus‐Induced carcinogenesis
  publication-title: Microorganisms
– year: 2022
– volume: 9
  start-page: 375
  year: 2022
  end-page: 395
  article-title: APOBEC3: friend or foe in human papillomavirus infection and oncogenesis?
  publication-title: Annual Review of Virology
– volume: 500
  start-page: 415
  year: 2013
  end-page: 421
  article-title: Signatures of mutational processes in human cancer
  publication-title: Nature
– volume: 25
  start-page: 1560.e1
  year: 2019
  end-page: 1560.e7
  article-title: Prevalence of human papillomavirus, human immunodeficiency virus and other sexually transmitted infections among female sex workers in Togo: a national cross‐sectional survey
  publication-title: Clin Microbiol Infect
– volume: 215
  start-page: 403
  year: 1990
  end-page: 410
  article-title: Basic local alignment search tool
  publication-title: J Mol Biol
– volume: 62
  start-page: R269
  year: 2019
  end-page: R287
  article-title: The APOBEC3 genes and their role in cancer: insights from human papillomavirus
  publication-title: J Mol Endocrinol
– volume: 148
  year: 2021
  article-title: Evidence that the viral oncoproteins E6 and E7 of HPV induce the expression of a functional IL‐2R on cervical cancer cells
  publication-title: Cytokine
– volume: 118
  start-page: 1071
  year: 2006
  end-page: 1076
  article-title: Genome variation of human papillomavirus types: phylogenetic and medical implications
  publication-title: Int J Cancer
– volume: 11
  start-page: 886
  year: 2020
  article-title: Mutations in the HPV16 genome induced by APOBEC3 are associated with viral clearance
  publication-title: Nat Commun
– volume: 45
  start-page: 977
  year: 2013
  end-page: 983
  article-title: Evidence for APOBEC3B mutagenesis in multiple human cancers
  publication-title: Nature Genet
– volume: 131
  start-page: 2349
  year: 2012
  end-page: 2359
  article-title: Human papillomavirus types in 115,789 HPV‐positive women: a meta‐analysis from cervical infection to cancer
  publication-title: Int J Cancer
– volume: 195
  start-page: 1582
  year: 2007
  end-page: 1589
  article-title: A 2‐Year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or Low‐Grade squamous intraepithelial lesion
  publication-title: J Infect Dis
– volume: 1
  year: 2016
  article-title: Mechanistic signatures of HPV insertions in cervical carcinomas
  publication-title: NPJ Genom Med
– volume: 110
  start-page: 525
  year: 2006
  end-page: 541
  article-title: Molecular biology of human papillomavirus infection and cervical cancer
  publication-title: Clin Sci
– volume: 218
  start-page: 1027
  year: 2018
  end-page: 1036
  article-title: Presence of human papillomavirus (HPV) apolipoprotein B messenger RNA editing, catalytic Polypeptide‐Like 3 (APOBEC)‐related minority variants in HPV‐16 genomes from anal and cervical samples but not in HPV‐52 and HPV‐58
  publication-title: J Infect Dis
– volume: 144
  start-page: 1941
  year: 2019
  end-page: 1953
  article-title: Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
  publication-title: Int J Cancer
– volume: 12
  start-page: 1437
  year: 2020
  article-title: Characterization and diversity of 243 complete human papillomavirus genomes in cervical swabs using next generation sequencing
  publication-title: Viruses
– volume: 5
  start-page: 2624
  year: 2013
  end-page: 2642
  article-title: Role of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune response
  publication-title: Viruses
– volume: 8
  start-page: 10548
  year: 2015
  end-page: 10557
  article-title: APOBEC3A possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer
  publication-title: Int J Clin Exp Med
– volume: 7
  start-page: 2485
  year: 2015
  end-page: 2506
  article-title: High‐Risk human papillomavirus targets crossroads in immune signaling
  publication-title: Viruses
– volume: 10
  start-page: 773
  year: 2021
  article-title: E6/E7 variants of human papillomavirus 16 associated with cervical carcinoma in women in Southern Mexico
  publication-title: Pathogens
– volume: 45
  start-page: D499
  year: 2017
  end-page: D506
  article-title: The papillomavirus episteme: a major update to the papillomavirus sequence database
  publication-title: Nucleic Acids Res
– volume: 15
  start-page: 22
  year: 2020
  article-title: Cervical, anal and oral HPV detection and HPV type concordance among women referred for colposcopy
  publication-title: Infect Agent Cancer
– volume: 25
  start-page: 1754
  year: 2009
  end-page: 1760
  article-title: Fast and accurate short read alignment with Burrows‐Wheeler transform
  publication-title: Bioinformatics
– volume: 92
  year: 2018
  article-title: The human papillomavirus E6 oncoprotein targets USP15 and TRIM25 to suppress RIG‐I‐Mediated innate immune signaling
  publication-title: J Virol
– volume: 92
  start-page: e00017
  year: 2018
  end-page: e00018
  article-title: Within‐Host variations of human papillomavirus reveal APOBEC signature mutagenesis in the viral genome
  publication-title: J Virol
– volume: 485
  start-page: 460
  year: 2015
  end-page: 466
  article-title: Detection of hypermutated human papillomavirus type 16 genome by next‐generation sequencing
  publication-title: Virology
– volume: 14
  start-page: 2550
  year: 2005
  end-page: 2556
  article-title: Anal human papillomavirus infection in women and its relationship with cervical infection
  publication-title: Cancer Epidemiol Biomarkers Prevent
– volume: 314
  start-page: 111
  year: 1985
  end-page: 114
  article-title: Structure and transcription of human papillomavirus sequences in cervical carcinoma cells
  publication-title: Nature
– volume: 348
  start-page: 518
  year: 2003
  end-page: 527
  article-title: Epidemiologic classification of human papillomavirus types associated with cervical cancer
  publication-title: N Engl J Med
– volume: 9
  start-page: 233
  year: 2017
  article-title: Roles of APOBEC3A and APOBEC3B in human papillomavirus infection and disease progression
  publication-title: Viruses
– volume: 445
  start-page: 80
  year: 2013
  end-page: 98
  article-title: The E4 protein; structure, function and patterns of expression
  publication-title: Virology
– volume: 23
  start-page: 719
  year: 2022
  end-page: 728
  article-title: Cancer in sub‐Saharan Africa in 2020: a review of current estimates of the national burden, data gaps, and future needs
  publication-title: Lancet Oncol
– volume: 15
  year: 2019
  article-title: Roles for E1‐independent replication and E6‐mediated p53 degradation during low‐risk and high‐risk human papillomavirus genome maintenance
  publication-title: PLoS Pathog
– volume: 170
  start-page: 1164
  year: 2017
  end-page: 1174.e6
  article-title: HPV16 E7 genetic conservation is critical to carcinogenesis
  publication-title: Cell
– ident: e_1_2_9_24_1
  doi: 10.1038/s41467-020-14730-1
– ident: e_1_2_9_16_1
  doi: 10.1038/nature12477
– ident: e_1_2_9_10_1
  doi: 10.1016/j.virol.2014.12.028
– ident: e_1_2_9_28_1
  doi: 10.1016/S1473-3099(19)30164-1
– ident: e_1_2_9_34_1
  doi: 10.1097/OLQ.0b013e3181f70253
– ident: e_1_2_9_18_1
  doi: 10.1038/ng.2702
– ident: e_1_2_9_32_1
  doi: 10.1158/1055-9965.EPI-05-0460
– ident: e_1_2_9_27_1
  doi: 10.1016/j.cmi.2019.04.015
– ident: e_1_2_9_50_1
  doi: 10.1093/annonc/mdy003
– volume: 8
  start-page: 10548
  year: 2015
  ident: e_1_2_9_21_1
  article-title: APOBEC3A possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer
  publication-title: Int J Clin Exp Med
  contributor:
    fullname: Chen S
– ident: e_1_2_9_52_1
  doi: 10.1093/nar/gkw879
– ident: e_1_2_9_44_1
  doi: 10.1016/j.virol.2015.08.017
– ident: e_1_2_9_8_1
– ident: e_1_2_9_54_1
  doi: 10.1093/gigascience/giab008
– ident: e_1_2_9_49_1
  doi: 10.1371/journal.ppat.1007755
– ident: e_1_2_9_40_1
  doi: 10.1016/j.cyto.2021.155592
– ident: e_1_2_9_46_1
  doi: 10.1093/infdis/jiy287
– ident: e_1_2_9_20_1
  doi: 10.1128/JVI.02383-14
– ident: e_1_2_9_45_1
  doi: 10.1128/JVI.00017-18
– ident: e_1_2_9_12_1
  doi: 10.3390/v12121437
– ident: e_1_2_9_41_1
  doi: 10.1128/JVI.01737-17
– ident: e_1_2_9_30_1
  doi: 10.1007/s00404-013-2821-0
– ident: e_1_2_9_3_1
  doi: 10.1086/516784
– ident: e_1_2_9_6_1
  doi: 10.1016/S1470-2045(22)00270-4
– ident: e_1_2_9_38_1
  doi: 10.1042/CS20050369
– ident: e_1_2_9_43_1
  doi: 10.1530/JME-19-0011
– ident: e_1_2_9_55_1
  doi: 10.1038/msb.2011.75
– ident: e_1_2_9_15_1
  doi: 10.7150/ijms.34279
– ident: e_1_2_9_23_1
  doi: 10.1128/mBio.02234-14
– ident: e_1_2_9_56_1
  doi: 10.1016/S0022-2836(05)80360-2
– ident: e_1_2_9_51_1
  doi: 10.1038/npjgenmed.2016.4
– ident: e_1_2_9_53_1
  doi: 10.1093/bioinformatics/btp324
– ident: e_1_2_9_48_1
  doi: 10.1002/ijc.27485
– ident: e_1_2_9_42_1
  doi: 10.3390/v5112624
– ident: e_1_2_9_7_1
– ident: e_1_2_9_29_1
  doi: 10.1186/s13027-020-00287-7
– ident: e_1_2_9_39_1
  doi: 10.3390/v7052485
– ident: e_1_2_9_2_1
  doi: 10.1093/jnci/djn044
– ident: e_1_2_9_17_1
  doi: 10.1038/ng.2701
– ident: e_1_2_9_22_1
  doi: 10.3390/v9080233
– ident: e_1_2_9_33_1
  doi: 10.1371/journal.pone.0265269
– ident: e_1_2_9_19_1
  doi: 10.1126/science.1153201
– ident: e_1_2_9_31_1
  doi: 10.1016/j.jcv.2018.05.010
– ident: e_1_2_9_37_1
  doi: 10.1038/314111a0
– ident: e_1_2_9_13_1
  doi: 10.3390/microorganisms7070199
– ident: e_1_2_9_5_1
  doi: 10.1002/ijc.31937
– ident: e_1_2_9_14_1
  doi: 10.3390/pathogens10060773
– ident: e_1_2_9_47_1
  doi: 10.1093/cid/cix135
– ident: e_1_2_9_25_1
  doi: 10.1146/annurev-virology-092920-030354
– ident: e_1_2_9_11_1
  doi: 10.1002/ijc.21655
– ident: e_1_2_9_26_1
– ident: e_1_2_9_35_1
  doi: 10.1016/j.virol.2013.07.008
– ident: e_1_2_9_36_1
  doi: 10.1016/j.cell.2017.08.001
– ident: e_1_2_9_4_1
  doi: 10.1002/ijc.30716
– ident: e_1_2_9_9_1
  doi: 10.1056/NEJMoa021641
SSID ssj0008922
Score 2.470354
Snippet High‐risk human papillomavirus (HPV) infections are responsible for cervical cancer. However, little is known about the differences between HPV types and risk...
High-risk human papillomavirus (HPV) infections are responsible for cervical cancer. However, little is known about the differences between HPV types and risk...
Abstract High‐risk human papillomavirus (HPV) infections are responsible for cervical cancer. However, little is known about the differences between HPV types...
SourceID proquest
crossref
pubmed
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage e70002
SubjectTerms Adult
anal
Anal Canal - virology
APOBEC Deaminases - genetics
APOBEC3
Carcinogens
cervical
Cervical cancer
Cervix Uteri - virology
Conserved sequence
Cytidine Deaminase - genetics
E6 gene
Editing
Female
Gene sequencing
Genes
Genetic diversity
Genetic Variation
Genome, Viral - genetics
Genomes
High-Throughput Nucleotide Sequencing
Human papillomavirus
Humans
Immune response
Innate immunity
Mutation
Nucleotide sequence
Papillomaviridae - classification
Papillomaviridae - genetics
Papillomavirus Infections - genetics
Papillomavirus Infections - virology
Risk
Sex Workers
Whole Genome Sequencing
Young Adult
Title Viral whole genome sequencing reveals high variations in APOBEC3 editing between HPV risk categories
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjmv.70002
https://www.ncbi.nlm.nih.gov/pubmed/39400339
https://www.proquest.com/docview/3119815247
https://www.proquest.com/docview/3116338954
Volume 96
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bS8MwFD6oD-KL90u9EcUHXzrbJG1afPLKGEyH6PBBKG2SyZR1MjcFf70nTbuhIohvhdzanJzkO8nXLwAHUqiwQ6PAlZwrl1Ou3ShSITqe4CpAQGIV-JpXYf2ON-6D-yk4rv6FsfoQ4w034xnFfG0cPM1ejyaioU-9t5rwrJCkz4Shc53fTKSjotieIOBM4OIaFFSqQh49Gpf8uhb9AJhf8Wqx4FwuwEP1qpZn8lwbDbOa_Pim4vjPb1mE-RKIkhM7cpZgSufLMNssj9pXQLW7A0x_N_fnEqPk2tOk5F3jakeM8hOOXGLkjskbBtx25490c3LSuj69OGMEqzKcalJSwUi91SaGyU4MCeuxb2L0Vbi7vLg9q7vllQyupMJgccR7vpQqpmFHKN_PdBZwLVnW8bTyAplKxFPaYBbG0sDLhPQlAgLNI6YkRndsDWbyfq43gHgKsRbHgoJJnrIM8bOMYqxTyw6VKnRgvzJO8mKVNxKrsUwT7K-k6C8HtiuzJaXzvSbM9-MIcQkXDuyNk9FtzFlImuv-qMgTYnQeB9yBdWvucSvFZfGMxQ4cFkb7vfmk0WwXD5t_z7oFcxSBkSUEbsPMcDDSOwhshtkuTFPe2i3G8ScWw_Lx
link.rule.ids 315,783,787,1378,11576,27938,27939,46066,46308,46490,46732
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LSwMxEB6KgnoR365WjeLBy9rdJPsCL1Vaam21B1u8Ld0klQpuRdv6950k2xURwdtCXjCTyXyTzH4DcC4iGY5oHLiCc-lyypUbxzJEw4u4DBCQWAa-7n3Y6vP2U_BUgavFvzCWH6K8cNOWYc5rbeD6Qrr2zRr68jq_jDzDJLnMQ57owg2U98pzOE7sGwKeBS56oWDBK-TRWjn0pzf6BTF_IlbjcpobsF5gRVK3yt2Eisq3YKVbvIZvgxyM37H9U5e4JZps9VWRIjUaHRLR5Ey4uYhmJCZzjInt5RwZ56Tee7hu3DCCU-m0Z1Jka5FWb0B0sjnReVLPEx1G70C_2Xi8ablF1QRX0EjDZYRkvhAyoeEokr6fqSzgSrBs5CnpBWIoEPIoDSsYGwZeFglfoM9WPGZSYADGdmEpn-RqH4gnEQ5xHBgxwYcsQ4gr4gTnVGJEhQwdOFtIL32z5BippUGmKYo4NSJ2oLqQa1rYx0fKfD-JETrwyIHTshl3tn6uGOZqMjN9Qgygk4A7sGf1Ua5i6rkzljhwYRT09_JpuzswHwf_73oCq63Hbift3N7fHcIaRRxj8_eqsDR9n6kjxCHT7Nhsty8ZN9V6
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LS8NAEB5KBfEivo1WXcWDl9gku3nhyVep1dYetHgLze5GKphKbevfd3Y3iRQRvAX2BbM7M9_sTr4BOOWhCDIv8m3OmLCZx6QdRSJAxQuZ8BGQGAa-bi9oP7POi_9Sg4vyXxjDD1FduCnN0PZaKfiHyJo_pKFv7_Pz0NFEkktMwXBF68z6lRmOYvOEgKbARifkl7RCjteshi46o18IcxGwao_TWoPVAiqSS7O361CT-QYsd4vH8E0Qg9EE279UhVuiuFbfJSkyo9EfEcXNhGeLKEJiMseQ2NzNkVFOLvuPV7fXlOBUKuuZFMlapN0fEJVrTlSa1OtYRdFb8Ny6fbpu20XRBJt7oULLiMhczkXsBVkoXDeVqc8kp2nmSOH4fMgR8UiFKigd-k4acpejy5YsooJj_EW3oZ6Pc7kLxBGIhhgODClnQ5oiwuVRjHNKnnlcBBaclNJLPgw3RmJYkL0ERZxoEVvQKOWaFOrxmVDXjSNEDiy04LhqxoOtXiuGuRzPdJ8A4-fYZxbsmP2oVtHl3CmNLTjTG_T38kmnO9Afe__vegTL_ZtW8nDXu9-HFQ9RjMnea0B9OpnJA0Qh0_RQn7Zv5yrUow
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Viral+whole+genome+sequencing+reveals+high+variations+in+APOBEC3+editing+between+HPV+risk+categories&rft.jtitle=Journal+of+medical+virology&rft.au=Ferr%C3%A9%2C+Valentine+Marie&rft.au=Copp%C3%A9e%2C+Romain&rft.au=Gbeasor%E2%80%90Komlanvi%2C+Fifonsi+A.&rft.au=Vacher%2C+Sophie&rft.date=2024-10-01&rft.issn=0146-6615&rft.eissn=1096-9071&rft.volume=96&rft.issue=10&rft_id=info:doi/10.1002%2Fjmv.70002&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_jmv_70002
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0146-6615&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0146-6615&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0146-6615&client=summon